Scandinavian Real Heart Investor Relations Material

Scandinavian Real Heart AB is a medical technology company based in Sweden that specializes in the development of artificial heart devices. The company's primary product is a heart pump designed to mimic the body's natural circulatory system, serving as a temporary solution for patients awaiting heart transplants. The artificial heart, known as the Realheart TAH, aims to replicate the human heart's function by providing a pulsatile blood flow, which is crucial for maintaining organ health during the transplant waiting period. The company is headquartered in Västerås, Sweden, and its shares are listed on the Nasdaq Stockholm.